Company profile: Sudo Biosciences
1.1 - Company Overview
Company description
- Provider of TYK2 pseudokinase domainβtargeting medicines, including a brain-penetrant TYK2 inhibitor for multiple sclerosis and neurodegenerative diseases, and a topical TYK2 inhibitor for psoriasis and other immune-mediated dermatologic conditions.
Products and services
- Topical TYK2 inhibitor: Dermatology-grade topical TYK2 pseudokinase-domain inhibitor developed to treat psoriasis and other immune-mediated dermatologic conditions with localized cutaneous delivery
- Brain-penetrant TYK2 inhibitor: Small-molecule targeting the TYK2 pseudokinase domain, engineered to penetrate the brain for multiple sclerosis and neurodegenerative disease modulation
- TYK2 pseudokinase-domain medicines program: Custom-engineered program that architects and develops medicines targeting the TYK2 pseudokinase domain for neurodegenerative diseases, multiple sclerosis, psoriasis, and other immune-mediated dermatologic conditions
Key contacts
π
π
Financial details
π
1.2 - Competitors and similar companies to Sudo Biosciences
Graviton
HQ: United States
Website
- Description: Provider of novel therapeutics for autoimmune, cancer, certain genetic, fibrotic, and other serious diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Graviton company profile β
Statera Biopharma
HQ: United States
Website
- Description: Provider of biotechnology research services and immune-restorative drug development, advancing STAT-201 for pediatric Crohn's, STAT-205 for acute and post-acute COVID-19, STAT-401 as an adjunct for pancreatic cancer, the AIMS platform targeting complex pathways and toll-like receptors, and Entolimod, a TLR5 agonist for radio-mitigation in cancer patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Statera Biopharma company profile β
Epiva
HQ: United States
Website
- Description: Provider of immuno-microbiome therapeutics, developing immunobiotic therapeutics through a platform from Flagship VentureLabs, the innovation foundry of Flagship Ventures.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Epiva company profile β
Allergy Therapeutics
HQ: United Kingdom
Website
- Description: Provider of European-based speciality pharmaceutical expertise focused on the treatment and prevention of allergy, offering general information for allergy sufferers and healthcare professionals on prevention, diagnosis and treatment, with a special focus on allergy vaccination (also known as specific immunotherapy or desensitisation therapy).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Allergy Therapeutics company profile β
OMass Therapeutics
HQ: United Kingdom
Website
- Description: Provider of drug discovery leveraging novel mass spectrometry, offering the OdyssION platform that uses native mass spectrometry and custom chemistry to study target interactions in native ecosystems, and a small molecule pipeline targeting solute carriers, inflammasome complexes, and GPCRs for orphan and immunological diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full OMass Therapeutics company profile β
π
2.M&A buyers
2.1 Potential strategic acquirers in the sector
π
π
π
π
View all strategic buyers with complete profiles
Start Free Trial β
2.2 - Strategic buyer groups for Sudo Biosciences
π
Buyer group 1: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 2: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 3: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial β
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Sudo Biosciences
2.2 - Growth funds investing in similar companies to Sudo Biosciences
π
View all growth equity funds with complete profiles
Start Free Trial β
4 - Top valuation comps for Sudo Biosciences
4.2 - Public trading comparable groups for Sudo Biosciences
π Unlock all public trading comparable groups with complete valuation data
Start Free Trial β